Skip to main content

Table 1 Baseline characteristics

From: In vitro fertilisation with recombinant follicle stimulating hormone requires less IU usage compared with highly purified human menopausal gonadotrophin: results from a European retrospective observational chart review

Characteristic rFSH hMG-HP All Patients
Number of cycles    
All patients N (%) 22665 (74%) 7965 (26%) 30630
≤35 years N (%) 15422 (75%) 5142 (25%) 20564
≥36 years N (%) 7243 (72%) 2823 (28%) 10066
Age Mean (SD) 32.89 (3.57) 33.04 (3.71)1,2 32.93 (3.61)
  1. 1 p < 0.01 in Wilcoxon two sample test
  2. 2 p < 0.01 in two sample t-test